Grażyna Bochenek

Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics

Barbro Dahlén, Ewa Niżankowska, A Szczeklik et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 395 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Diagnosis and management of <scp>NSAID</scp>‐Exacerbated Respiratory Disease (N‐<scp>ERD</scp>)—a <scp>EAACI</scp> position paper

Marek L. Kowalski, Ioana Agache, Sevim Bavbek et al. · Allergy · 2018 · 346 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +15

U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza et al. · Journal of Allergy and Clinical Immunology · 2016 · 292 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +14

Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma

Andrzej Szczeklik, E Nizankowska, Grażyna Bochenek et al. · Clinical & Experimental Allergy · 2001 · 187 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

Grażyna Bochenek, Krzysztof Nagraba, Ewa Niżankowska et al. · Journal of Allergy and Clinical Immunology · 2003 · 159 citations · Full text

Medicine, Biochemistry, Pharmacology +13